Molecular and Cellular Proteomics/American Society for Biochemistry and Molecular Biology Lectureship AwardThe 2025 Molecular and Cellular Proteomics (MCP) / American Society for Biochemistry and Molecular Biology (ASBMB) Lectureship Award will be presented to Dr. Rebakah L. Gundry during this year’s Society for Glycobiology (SFG) Annual meeting in San Diego, California. The MCP journal was created in 2001 to address the growing needs of the proteomics community. The MCP/ASBMB Lectureship Award was established in 2013 and has been bestowed upon a single scientist each year who is at the forefront of the emerging fields of glycomics and glycoproteomics. 2025 Awardee - Dr. Rebekah Gundry
Dr. Rebekah L. Gundry earned her Honors B.S. in Biochemistry and Molecular Biology from Marquette University in 1999 and an M.S. in Forensic Science from The George Washington University in 2001, completing her thesis at the FBI Forensic Science Research Unit. She received her Ph.D. in mass spectrometry at the Johns Hopkins University School of Medicine in 2006 under Dr. Robert J. Cotter and pursued postdoctoral training in cardiology at Johns Hopkins, with additional research at ETH Zürich and the NIH. During this time, she was awarded an NIH K99/R00 Pathway to Independence Award and a BD Biosciences Research Grant to advance her pioneering studies of stem cell surface proteins. In 2010, Dr. Gundry joined the Medical College of Wisconsin, where she established her independent laboratory and received the 2013 Robert J. Cotter Young Investigator Award from the U.S. Human Proteome Organization. In 2019, she was recruited to the University of Nebraska Medical Center (UNMC) as Department vice chair and inaugural Director of the CardiOmics Program. She now serves as the Stokes-Shackleford Professor and Chair of Cellular and Integrative Physiology, Director of the Center for Heart and Vascular Research, and Scientific Director of the UNMC Mass Spectrometry Core. As Principal Investigator of an $11.8 million NIH COBRE award, she has positioned UNMC as a national leader in translational cardiovascular research. Dr. Rebekah L. Gundry is a leading authority in mass spectrometry, proteomics, metabolomics, glycoproteomics, and bioinformatics, advancing the frontier of multiomics mass spectrometry. She has pioneered innovative methods for mapping cell surface glycoproteins and integrating multiomic datasets to uncover mechanisms of cardiovascular disease and stem cell differentiation. Her laboratory produced the first comprehensive map of human heart cell surface proteins, identifying cell type–specific therapeutic targets and providing novel insights into heart failure biology. To expand access to glycoproteomics, Dr. Gundry developed widely adopted tools and platforms, including CellSurfer, glyPAQ, and bioinformatics resources such as SurfaceGenie, CIRFESS, Veneer, and VISUN. These contributions have reshaped the field, enabled transformative biological discoveries, and advanced translational applications in precision medicine. Dr. Gundry’s outstanding contributions have been recognized through numerous honors, including election as a Fellow of the American Heart Association (2019), the NHLBI Emerging Investigator Award (2021), the Distinguished Scientist Award from UNMC (2021), and the Clinical and Translational Proteomics Award from the International Human Proteome Organization (2023). In recognition of her accomplishments, in particular her work in mass spectroscopy, Dr. Gundry was recommended by the SFG awards committee and selected by the editorial leadership of the MCP to receive the 2025 MCP Lectureship Award.
|
